Seeger Weiss LLP


Recent News About Seeger Weiss LLP View More

Judge: Settlement talks begun in mass action vs Abbvie, others over Androgel, testosterone drugs

By Jonathan Bilyk | Sep 10, 2018

A federal judge has put a hold on any further proceedings in the massive, years-long nationwide legal action against Abbvie and other makers of so-called testosterone replacement therapy drugs, saying he wants to give both sides time to complete a potential settlement drug to permanently end the litigation.

Judge orders new trial, tosses $140M verdict vs AbbVie over Androgel testosterone drug

By Jonathan Bilyk | Jul 5, 2018

A federal judge has knocked down a $140 million verdict against pharmaceutical maker AbbVie, ordering a new trial over a man’s claims AbbVie’s Androgel testosterone replacement therapy drug caused him to suffer a heart attack.

Verdict much lower, but AbbVie wants $3.2M award tossed in second testosterone class action test trial

By Dan Churney | Apr 30, 2018

North Chicago-based drugmaker AbbVie is resisting what it is calling a jury's “confused and inconsistent” $3.2 million verdict, after the company lost a second trial in Chicago federal court – one in which it was ordered to pay $147 million less than the first trial – over a man’s claims AbbVie allegedly failed to warn its product AndroGel could bring on a heart attack.

The Record Network